Imen Chamkha's Colleagues at Abliva AB
Imen Chamkha's Contact Details
HQ
+46 462756220
+46 462756220
Location
Tunisia
Tunisia
Company
Abliva AB
Abliva AB
Imen Chamkha's Company Details
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The company is focused on two projects. KL1333, a powerful NAD⁺ regulator, is in clinical development and has been granted orphan drug designation in Europe and the US. NV354, an energy replacement (succinate) therapy, is in preclinical development. Abliva, based in Lund, Sweden, is listed on Nasdaq Stockholm, Sweden (ticker: ABLI).
Frequently Asked Questions about Imen Chamkha
Imen Chamkha currently works for Abliva AB.
Imen Chamkha's role at Abliva AB is post-doc Researcher.
Imen Chamkha's email address is ***@abliva.com. To view Imen Chamkha's full email address, please signup to ConnectPlex.
Imen Chamkha works in the Pharmaceuticals industry.
Imen Chamkha's colleagues at Abliva AB are Ellen Donnelly and others.
Imen Chamkha's phone number is +46 462756220